Zoetis | Beneficio Operativo

Created with Highcharts 10.1.0Chart context menu


Operating Profit Cambio Fecha
AbbVie USD -1490000000 5.32B 2024-12
Align Technology USD 144.15M 18.15M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Dentsply International USD -509000000 47M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Henry Schein USD 155M 2M 2024-12
Idexx Laboratories USD 261.69M 42.21M 2024-12
Illumina USD 175M 566M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
J&J USD 3.89B 549M 2024-12
Laboratory Of America USD 216.5M 37.6M 2024-12
Merck USD 4.3B 369M 2024-12
Neogen USD -457484000 459.74M 2024-11
Pacira USD 24.7M 164.23M 2024-12
Patterson Companies USD 45.44M 7.8M 2025-01
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Quest Diagnostics USD 361M 8M 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
Sanofi EUR 3.64B 1.35B 2024-09
Zoetis USD 732M 142M 2024-12



Zoetis Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.